Pure Bioscience (PURE)
OTHER OTC:PURE

Pure Bioscience (PURE) Income Statement

40 Followers

Pure Bioscience Income Statement

Last quarter (Q3 2024), Pure Bioscience's total revenue was $441.00K, an increase of 11.08% from the same quarter last year. In Q3, Pure Bioscience's net income was $-857.00K. See Pure Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jul 23Jul 22Jul 21Jul 20Jul 19
Total Revenue
$ 1.90M$ 1.88M$ 1.85M$ 3.93M$ 6.92M$ 1.91M
Cost of Revenue
$ 401.00K$ 906.00K$ 853.00K$ 1.85M$ 2.90M$ 728.00K
Gross Profit
$ 1.07M$ 971.00K$ 1.00M$ 2.08M$ 4.02M$ 1.18M
Operating Expense
$ 2.30M$ 4.91M$ 4.72M$ 4.39M$ 4.02M$ 6.77M
Operating Income
$ -803.00K$ -3.94M$ -3.72M$ -2.31M$ 4.00K$ -5.59M
Net Non Operating Interest Income Expense
$ -105.00K$ -14.00K$ -6.00K$ -4.00K$ -5.00K$ -6.00K
Other Income Expense
$ -2.00K$ 319.00K$ 60.00K$ 4.00K$ 5.00K$ -959.00K
Pretax Income
$ -906.00K$ -3.96M$ -3.49M$ -2.32M$ 4.00K$ -6.55M
Tax Provision
-$ 1.65K$ 1.65K$ -1.65K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -906.00K$ -3.96M$ -3.49M$ -2.32M$ 4.00K$ -6.55M
Basic EPS
$ -0.05$ -0.04$ -0.04$ -0.03$ 0.00$ -0.09
Diluted EPS
$ -0.05$ -0.04$ -0.04$ -0.03$ 0.00$ -0.09
Basic Average Shares
$ 446.93M$ 111.40M$ 88.84M$ 87.17M$ 82.21M$ 72.88M
Diluted Average Shares
$ 446.93M$ 111.40M$ 88.84M$ 87.17M$ 84.61M$ 72.88M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 2.70M$ 5.82M$ 5.58M$ 6.24M$ 6.91M$ 7.50M
Net Income From Continuing And Discontinued Operation
$ -3.47M$ -3.96M$ -3.49M$ -2.32M$ 4.00K$ -6.55M
Normalized Income
$ -2.57M-$ -2.46M-$ 4.00K$ -5.59M
Interest Expense
----$ 5.00K$ 6.00K
EBIT
$ -801.00K$ -3.95M$ -3.48M$ -2.31M$ 9.00K$ -6.55M
EBITDA
$ -656.00K$ -3.83M$ -3.27M$ -2.14M$ 201.00K$ -6.31M
Currency in USD

Pure Bioscience Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis